1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Using Artificial Intelligence to Integrate Imaging and Genetic Markers for Personalized Breast Cancer Risk Prediction is sponsored by Lynn Sage Breast Cancer Foundation. This study aims to develop precise breast cancer risk prediction models by integrating genetic risk scores with artificial intelligence analysis of mammographic images.
The goal is to guide personalized screening decisions, such as when to start and how often to screen, to improve early detection and outcomes for women at highest risk through a multimodal approach.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Early Investigator Awards support early-career researchers, while Senior Investigator Awards fund experienced researchers. Universities and research institutions are eligible. Confirm the full requirements in the official notice before applying.
Using Artificial Intelligence to Integrate Imaging and Genetic Markers for Personalized Breast Cancer Risk Prediction is funded by Lynn Sage Breast Cancer Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read article